This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Transversus Abdominis Plane Block
and you are
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The aim of this study is to determine the effect of the addition of vasoconstrictor in the plasma concentrations achieved and the extent of the transversus abdominis plane block in healthy male volunteers.

Provided treatments

  • Drug: Levobupivacaine with epinephrine
  • Drug: Levobupivacaine without epinephrine
  • Other: Monitoring
  • Other: Determining the extent of the block

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01596998. The sponsor of the trial is Pontificia Universidad Catolica de Chile and it is looking for 11 volunteers for the current phase.
Official trial title:
Comparison of Plasma Concentrations of Levobupivacaine With and Without Epinephrine for Transversus Abdominis Plane Block Under Ultrasound.